Concord Biotech Limited is one of the most recognized names in the biopharmaceutical sector today. Home to an ultramodern fermentation facility and top of the line R&D division, Concord today offers fermentation & semi-synthetic potent & non-potent APIs. From our humble beginnings in 2000 where we had a single facility of an enzyme and now, to more than 20 Biotech blocks with more than 500 m3 fermentation capacity, we have surely come a long way. Today, we own a diverse and rich portfolio of Active Pharmaceutical Ingredients in the areas of Immunosuppressant, Antibiotics, Anti-fungal, Oncology, Statins, Anti-Obesity, Enzymes and others. Concord also offers contract research & manufacturing services in the areas of fermentation & semi-synthetic molecules whenever required. Quality is the essence of our work approach at Concord and therefore, we practice CGMP and have also been inspected & approved by Global Regulatory Agencies like USFDA, EU GMP, Japanese AFM, Local FDA, Korean FDA etc.